losartan has been researched along with alloxan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Salam, OM; Arbid, MS; el-Batran, SA; el-Shenawy, SM; Nofal, SM | 1 |
| Buhagiar, KA; Clarke, RJ; Garcia, A; Hamilton, E; Hansen, PS; Rasmussen, HH; White, C | 1 |
| Ali, AA; Elnagar, GM; Elseweidy, MM; M Elsawy, M; Zein, N | 1 |
3 other study(ies) available for losartan and alloxan
| Article | Year |
|---|---|
Studies on the glycemic and lipidemic effect of monopril and losartan in normal and diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Blood Proteins; Carbamates; Cholesterol, LDL; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Therapy, Combination; Egypt; Fosinopril; Gliclazide; Hyperlipidemias; Hypolipidemic Agents; Lipids; Losartan; Male; Piperidines; Rats; Rats, Sprague-Dawley; Triglycerides | 2004 |
Alloxan-induced diabetes reduces sarcolemmal Na+-K+ pump function in rabbit ventricular myocytes.
Topics: Alloxan; Angiotensin II Type 1 Receptor Blockers; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Heart Ventricles; Ion Channel Gating; Losartan; Male; Myocytes, Cardiac; Rabbits; Sarcolemma; Sodium-Potassium-Exchanging ATPase | 2007 |
Losartan and azelastine either alone or in combination as modulators for endothelial dysfunction and platelets activation in diabetic hyperlipidemic rats.
Topics: Alloxan; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Blood Platelets; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Endothelial Cells; Histamine H1 Antagonists, Non-Sedating; Hyperlipidemias; Hypolipidemic Agents; Losartan; Male; Phthalazines; Platelet Activation; Rats | 2020 |